COT Chair

Professor A Boobis
Professor A Boobis OBE PhD CBiol FSB FBTS Professor of Biochemical Pharmacology and Director of Toxicology Unit (funded by PHE & DH) in the Faculty of Medicine at Imperial College London

Professor Alan Boobis is currently Professor of Biochemical Pharmacology and Director of Toxicology Unit (funded by PHE & DH) in the Faculty of Medicine at Imperial College London. He has been a member of Imperial College London (initially at the Royal Postgraduate Medical School, which merged with the College in 1997) for almost 40 years.  His main research interests lie in mechanistic toxicology, drug metabolism, toxicity pathway analysis and in the application of knowledge in these areas to risk assessment.  He has published around 230 original research papers (H-factor 63) and for several years served as an Editor-in-Chief of Food and Chemical Toxicology.

He is a member of a number of national and international advisory committees, including the Committee on the Medical Effects of Air Pollutants, the WHO Study Group on Tobacco Product Regulation (TobReg) and the WHO Chemical Risk Assessment Network Coordinating Group. He is co-chair of the WHO Mode of Action Steering group, JECFA (veterinary residues – co-chair) and JMPR (alternating co-chair). He has been a member and deputy chair of the UK Advisory Committee on Pesticides, a member and deputy chair of the UK Committee on Toxicity (2003-2012), a member of the UK Committee on Carcinogenicity, the EFSA Panel on Contaminants in the Food Chain and a member and deputy chair of the EFSA Panel on Plant Protection Products.  He has also served as a member of the HPA Board Sub-Committee for Radiation, Chemical and Environmental Hazards and the Veterinary Residues Committee.

He is chair of the Board of Trustees of the International Life Sciences Institute (ILSI) a member and a past chair of the Board of Trustees of ILSI HESI and vice-president of the Board of Directors of ILSI Europe.  He is involved in several HESI, ILSI Research Foundation and ILSI Europe projects. He is a fellow of the Society of Biology and of the British Toxicology Society.  He has served as president and is an honorary member of Eurotox and received the Merit Award in 2009.  He is a past chair of the British Toxicology Society and received the John Barnes Prize Lectureship in 2013. He was recipient of the Royal Society of Chemistry Toxicology Award in 2013. He received an OBE in 2003 for his work on the risk assessment of pesticides.

Professor Boobis was appointed chair of the Committee on Toxicity with effect from 1 April, 2015 for 3 years.

Personal Interest - updated 21 April 2015

Shareholder

Bank Santander

Barclays Bank

BG Group

BT Group

Centrica

Iberdrola SA

National Grid

Lloyds

Membership

ILSI & ILSI HESI Board of Trustees

ILSI Europe Board of Directors

Science Advisory Board of Swiss Centre for Applied Human Toxicology

SAB of Innovative Medicines Initiative “Drug-Induced Liver Injury”

Non Personal Interest - updated 21 April 2015

Support by Industry

GSK/MRC CASE PhD studentship

CEFIC/LRI

Other public appointments

WHO/FAO JMPR

WHO/FAO JECFA (vet)

WHO TobReg

WG10 TC126 (Intense Machine-smoking Regime for Testing Cigarettes)